Crossmark

Erenumab para el tratamiento de migraña crónica farmacorresistente

Crossref DOI link: https://doi.org/10.1016/j.medcli.2021.03.021

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Layos-Romero, Almudena

Andrés López, Alberto

Rojas Bartolomé, Laura
License Information

Text and Data Mining valid from 2022-01-01
More Information

This article is maintained by: Elsevier

Article Title: Erenumab para el tratamiento de migraña crónica farmacorresistente

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2021.03.021

Content Type: simple-article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.